October 12, 2020

COVID-19-related delays for CRC screening causing 11.9% increase in mortality

By: Judy Mathias

Editor's Note

New research presented October 12 at UEG [United European Gastroenterology] Week Virtual 2020 shows that delays in colorectal cancer (CRC) screening caused by COVID-19 has resulted in significantly increased mortality rates.

Researchers at the University of Bologna, Italy, developed a model to forecast the impact of delayed CRC screening on mortality. They found that:

Sponsored Message

  • moderate (7-12 months) delays caused a 3% increase in advanced stage CRC
  • large (more than 12 months) delays caused a 7% increase in advanced stage CRC.

Based on survival rates at 5 years for Stage III and IV CRC, the researchers found a significant 11.9% increase in mortality, when comparing a 0-3 month delay to a more than 12 month delay.

Healthcare authorities need to act urgently to reorganize activities during COVID-19, without compromising the diagnosis of other high-impact diseases like CRC, the researchers say.


Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

OR Manager Jobs
Live chat by BoldChat